Finance

Lists
9572:TADAWUL
Al-Razi Medical Company SJSC
23,00 SAR
-1,58%
(-0,37) 1D
15-окт., 15:00:00 GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 9572...
Open
23,00 SAR
High
23,00 SAR
Low
23,00 SAR
Mkt. cap
34,96 млн
Avg. vol.
8,65 миң
Volume
1,43 миң
P/E ratio
31,15
52-wk high
39,36 SAR
52-wk low
22,29 SAR
EPS
0,74 SAR
Shares outstanding
598,60 миң
No. of employees
123
Open
23,00 SAR
High
23,00 SAR
Low
23,00 SAR
Mkt. cap
34,96 млн
Avg. vol.
8,65 миң
Volume
1,43 миң
P/E ratio
31,15
52-wk high
39,36 SAR
52-wk low
22,29 SAR
EPS
0,74 SAR
Shares outstanding
598,60 миң
No. of employees
123
News stories
From web sources and news partners
About Al-Razi Medical Company SJSC
CEO-
Employees123
Founded1986
Headquarters-
SectorDrug
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
20,20 млн
20,20 млн
18,00 млн
18,00 млн
Cost of goods sold
15,18 млн
15,18 млн
13,14 млн
13,14 млн
Cost of revenue
15,18 млн
15,18 млн
13,14 млн
13,14 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,56 млн
4,56 млн
4,49 млн
4,49 млн
Operating expense
4,56 млн
4,56 млн
4,49 млн
4,49 млн
Total operating expenses
19,74 млн
19,74 млн
17,62 млн
17,62 млн
Operating income
457,26 миң
457,26 миң
374,95 миң
374,95 миң
Other non operating income
120,22 миң
120,22 миң
91,58 миң
91,58 миң
EBT including unusual items
391,28 миң
391,28 миң
276,97 миң
276,97 миң
EBT excluding unusual items
388,26 миң
388,26 миң
276,97 миң
276,97 миң
Income tax expense
39,53 миң
39,53 миң
67,50 миң
67,50 миң
Effective tax rate
10,10%
10,10%
24,37%
24,37%
Other operating expenses
-
-
-
-
Net income
351,75 миң
351,75 миң
209,47 миң
209,47 миң
Net profit margin
1,74%
1,74%
1,16%
1,16%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-189,22 миң
-189,22 миң
-189,55 миң
-189,55 миң
Net interest expenses
-189,22 миң
-189,22 миң
-189,55 миң
-189,55 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
895,62 миң
895,62 миң
810,76 миң
810,76 миң
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору